Clinical Trial Detail

NCT ID NCT01867333
Title Enzalutamide With or Without Vaccine Therapy for Advanced Prostate Cancer
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

prostate cancer

Therapies

PROSTVAC-F/TRICOM

Enzalutamide

Age Groups: adult

No variant requirements are available.